関連する実験動画

Updated: Jan 7, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

524

急性リンパ性白血病に対する絶滅渦を活用する

Peng Chen1,2, Sydney Murphy3, Huiqing Yeo4

  • 1Genomic Sciences and Systems Biology, Cleveland Clinic Research, Cleveland, OH, USA.

Evolution, medicine, and public health
|January 5, 2026
PubMed
まとめ

No abstract available in PubMed .

キーワード:
急性リンパ性白血病薬剤耐性絶滅療法絶滅渦

さらに関連する動画

In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)
06:48

In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)

Published on: August 1, 2025

439
Author Spotlight: Identification and Isolation of Quiescent Leukemia Stem Cells from Zebrafish T-ALL
06:41

Author Spotlight: Identification and Isolation of Quiescent Leukemia Stem Cells from Zebrafish T-ALL

Published on: July 19, 2024

1.3K

関連する実験動画

Last Updated: Jan 7, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

524
In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)
06:48

In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)

Published on: August 1, 2025

439
Author Spotlight: Identification and Isolation of Quiescent Leukemia Stem Cells from Zebrafish T-ALL
06:41

Author Spotlight: Identification and Isolation of Quiescent Leukemia Stem Cells from Zebrafish T-ALL

Published on: July 19, 2024

1.3K

関連する概念動画

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

Which evolutionary game-theoretic model best captures NSCLC dynamics?

PloS one·2026

Cancer Evolvability Determines Therapy Outcomes.

bioRxiv : the preprint server for biology·2026

Genome sequencing and multi-stage, blood-feeding, and tissue-specific transcriptome atlas of the Rocky Mountain wood tick provide a critical resource for this vector.

bioRxiv : the preprint server for biology·2026

Modeling VEGF and GLUT1 Expression as Coadapted Foraging Strategies in Cancer.

bioRxiv : the preprint server for biology·2026

Inverse game theory characterizes frequency-dependent selection driven by karyotypic diversity in triple-negative breast cancer.

PLoS computational biology·2026

Migrastatic therapy as a potential game-changer in adaptive cancer treatment.

Scientific reports·2026

Traditionalism mediates social learning: Biases in acceptance of novel health interventions among Himba pastoralists.

Evolution, medicine, and public health·2026

Childhood appendectomy is linked with higher digestive, respiratory, and genitourinary disease risk but lower inflammatory bowel disease risk.

Evolution, medicine, and public health·2026

Built environment is a key driver of cardiometabolic health in two Indigenous groups undergoing rapid lifestyle change.

Evolution, medicine, and public health·2026

Competitive suppression and release in artemisinin-resistant <i>Plasmodium falciparum</i> field isolates.

Evolution, medicine, and public health·2026

An evolutionary medicine perspective on the design of non-hormonal contraceptives for women.

Evolution, medicine, and public health·2026

Daughters-in-law and mothers-in-law in lowland rural Nepal: The balance of power and health outcomes.

Evolution, medicine, and public health·2026

Clinical characteristics, surgical management, and outcomes of uterine smooth muscle tumours of uncertain malignant potential: a single-centre experience.

Przeglad menopauzalny = Menopause review·2026

BCR-ABL1 Transcript Variants in Chronic Myeloid Leukemia Patients in Africa: A Systematic Review.

Health science reports·2026

Classical Hodgkin Lymphoma Today.

Mediterranean journal of hematology and infectious diseases·2026

Jiedu Xiaoliu formula enhances progression-free survival and immune modulation in diffuse large B-cell lymphoma: a retrospective cohort study.

Frontiers in pharmacology·2026

LTF promotes central nervous system leukemia progression via neutrophil serine proteases.

Frontiers in pharmacology·2026

Case Report: refractory hemophagocytic lymphohistiocytosis progression despite complete metabolic response in a patient with stage IV extranodal NK/T-cell lymphoma: clinical observation of "tumor-immune dissociation" phenomenon.

Frontiers in immunology·2026
関連記事をすべて見る
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー
Jove
Visualize
お問い合わせ